Eli Lilly and Company

BEBTELOVIMAB

Manufacturer:

Eli Lilly and Company

Name:

BEBTELOVIMAB

Category:

Q Code

HCPCS:

Q0222

NDC(s):

00310-7442-02, 00002-7589-01,

Primary Type:

COVID-19

Route of Administration:

Intravenous

About:

BEBTELOVIMAB is a COVID-19 drug manufactured by Eli Lilly and Company and administered via the Intravenous route of administration. The Q Code: Q0222 is aligned to the drug BEBTELOVIMAB.

Access Pricing and More By Registering